Data / Form D filings / Rejoni, Inc.
Rejoni, Inc.: Form D filings
Rejoni, Inc., a biotechnology company in Bedford, MA, filed 4 Form D notices with the SEC between 2020 and 2023. The latest, on October 18, 2023, reports $26.3 million sold of a $26.3 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 BURLINGTON RD., Bedford, MA, 01730
- Phone
- (617) 510-3859
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1824241
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 18, 2023 | Amendment | $26,250,000 | $26,250,000 | 22 | Dec 5, 2022 | sec.gov | |
| Feb 15, 2023 | Amendment | $26,000,001 | $26,000,001 | 21 | Dec 5, 2022 | sec.gov | |
| Dec 16, 2022 | New notice | $25,000,001 | $25,000,001 | 20 | Dec 5, 2022 | sec.gov | |
| Sep 15, 2020 | New notice | $15,000,001 | $15,000,001 | 20 | Sep 4, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Guneesh Batra | Director | |
| Amarpreet Sawhney | Executive Officer, Director | |
| Nicholas Svencer | Executive Officer, Director | |
| Farhad Khosravi | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Oct 16, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rejoni, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.